<!–
Market News
–>
June 27, 2017 – By Marguerite Chambers
Analysts expect NutraFuels Inc (OTCMKTS:NTFU) to report $0.00 EPS on July, 5. The stock decreased 3.19% or $0.015 on June 26, reaching $0.455. About 8,658 shares traded. NutraFuels Inc (OTCMKTS:NTFU) has 0.00% since June 27, 2016 and is . It has underperformed by 16.70% the SP500.
Cardinal Capital Management decreased Novartis Adr (NVS) stake by 14.77% reported in 2016Q4 SEC filing. Cardinal Capital Management sold 4,938 shares as Novartis Adr (NVS)’s stock rose 4.17%. The Cardinal Capital Management holds 28,486 shares with $2.08 million value, down from 33,424 last quarter. Novartis Adr now has $223.85B valuation. The stock decreased 0.68% or $0.59 during the last trading session, reaching $85.75. About shares traded. Novartis AG (ADR) (NYSE:NVS) has risen 7.67% since June 27, 2016 and is uptrending. It has underperformed by 9.03% the SP500.
NutraFuels, Inc. manufactures and distributes oral spray nutritional and dietary products. The company has market cap of $32.09 million. The Company’s oral spray products are designed to provide more absorption than capsules or liquid formulas. It currently has negative earnings. The Company’s products include NutraFuels sleep spray; NutraFuels Energy Spray; NutraFuels Garcinia Cambogia Spray; NutraFuels Headache and Pain Spray, and NutraFuels Hair, Skin and Nails Spray.
Analysts await Novartis AG (ADR) (NYSE:NVS) to report earnings on July, 18. They expect $1.18 earnings per share, down 3.28% or $0.04 from last year’s $1.22 per share. NVS’s profit will be $3.08B for 18.17 P/E if the $1.18 EPS becomes a reality. After $1.13 actual earnings per share reported by Novartis AG (ADR) for the previous quarter, Wall Street now forecasts 4.42% EPS growth.
Among 14 analysts covering Novartis Ag (NYSE:NVS), 4 have Buy rating, 2 Sell and 8 Hold. Therefore 29% are positive. Novartis Ag had 22 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Underperform” rating by Morgan Stanley given on Tuesday, April 12. The rating was upgraded by Argus Research on Thursday, November 10 to “Buy”. J P Morgan Chase Co maintained the shares of NVS in report on Friday, June 16 with “Neutral” rating. On Wednesday, March 8 the stock rating was upgraded by Societe Generale to “Buy”. Leerink Swann downgraded Novartis AG (ADR) (NYSE:NVS) rating on Wednesday, March 23. Leerink Swann has “Market Perform” rating and $85 target. The stock of Novartis AG (ADR) (NYSE:NVS) earned “Neutral” rating by UBS on Friday, April 1. The firm earned “Buy” rating on Monday, October 10 by Chardan Capital Markets. The firm earned “Market Perform” rating on Wednesday, April 5 by Cowen Co. The stock has “Buy” rating by Chardan Capital Markets on Tuesday, September 20. Credit Suisse downgraded the stock to “Neutral” rating in Wednesday, January 11 report.
Receive News Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our daily email newsletter.